E-LIB Suche - Ergebnisse für: Estrov, Zeev

1

Sotatercept for anemia of myelofibrosis: a phase II investi..:

Bose, Prithviraj ; Masarova, Lucia ; Pemmaraju, Naveen...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

2

P1025: A PILOT STUDY OF THE ANTI-SLAMF7 MONOCLONAL ANTIBODY..:

Bose, Prithviraj ; Masarova, Lucia ; Pemmaraju, Naveen...
HemaSphere. 7 (2023) S3 - p. e5738496 , 2023

Link: https://doi.org/10.1097/..

3

The role of therapy in the outcome of patients with myelofi..:

Masarova, Lucia ; Bose, Prithviraj ; Pemmaraju, Naveen...
Cancer. 129 (2023) 18 - p. 2828-2835 , 2023

Link: https://doi.org/10.1002/..

4

CLL-162 PTX3 is Constitutively Active in CLL Cells:

Rozovski, Uri ; Veletik, Ivo ; Harris, David...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S271 , 2022

Link: https://doi.org/10.1016/..

5

MPN-355 Patients With Prefibrotic Myelofibrosis and Inferio..:

Masarova, Lucia ; Bose, Prithviraj ; Pemmaraju, Naveen...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S334-S335 , 2022

Link: https://doi.org/10.1016/..

6

Improved survival of patients with myelofibrosis in the las..:

Masarova, Lucia ; Bose, Prithviraj ; Pemmaraju, Naveen...
Cancer. 128 (2022) 8 - p. 1658-1665 , 2022

Link: https://doi.org/10.1002/..

7

GLI1 activates pro-fibrotic pathways in myelofibrosis fibro..:

Manshouri, Taghi ; Veletic, Ivo ; Li, Ping...
Cell Death & Disease. 13 (2022) 5 - p. , 2022

Link: https://doi.org/10.1038/..

8

Poster: MPN-355 Patients With Prefibrotic Myelofibrosis and..:

Masarova, Lucia ; Bose, Prithviraj ; Pemmaraju, Naveen...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S158 , 2022

Link: https://doi.org/10.1016/..

9

Poster: MPN-354 Characteristics of Patients With Myelofibro..:

Masarova, Lucia ; Bose, Prithviraj ; Pemmaraju, Naveen...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S158 , 2022

Link: https://doi.org/10.1016/..

10

MPN-354 Characteristics of Patients With Myelofibrosis Taki..:

Masarova, Lucia ; Bose, Prithviraj ; Pemmaraju, Naveen...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S334 , 2022

Link: https://doi.org/10.1016/..

11

TP53‐altered chronic lymphocytic leukemia treated with firs..:

Cherng, Hua‐Jay J. ; Khwaja, Raamis ; Kanagal‐Shamanna, Rashmi...
American Journal of Hematology. 97 (2022) 8 - p. 1005-1012 , 2022

Link: https://doi.org/10.1002/..

12

Poster: CLL-162 PTX3 is Constitutively Active in CLL Cells:

Rozovski, Uri ; Veletik, Ivo ; Harris, David...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S142 , 2022

Link: https://doi.org/10.1016/..

13

Activation and expansion of T-follicular helper cells in ch..:

Vaca, Alicia M. ; Ioannou, Nikolaos ; Sivina, Mariela...
Leukemia. 36 (2022) 5 - p. 1324-1335 , 2022

Link: https://doi.org/10.1038/..

14

Phase 2 study of lenalidomide maintenance for patients with..:

Abou Dalle, Iman ; Kantarjian, Hagop M. ; Ravandi, Farhad...
Cancer. 127 (2021) 11 - p. 1894-1900 , 2021

Link: https://doi.org/10.1002/..

15

Activity of venetoclax-based therapy in chronic myelomonocy..:

Montalban-Bravo, Guillermo ; Hammond, Danielle ; DiNardo, Courtney D....
Leukemia. 35 (2021) 5 - p. 1494-1499 , 2021

Link: https://doi.org/10.1038/..